GSA CAPITAL PARTNERS LLP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$360,000
+35.3%
616,402
+64.7%
0.05%
+50.0%
Q1 2022$266,000
-40.5%
374,276
+10.5%
0.04%
-35.7%
Q4 2021$447,000
-48.1%
338,756
-9.6%
0.06%
-36.4%
Q3 2021$862,000
-57.1%
374,811
+35.6%
0.09%
-73.6%
Q1 2021$2,007,000
+4263.0%
276,381
+2484.0%
0.33%
+4062.5%
Q4 2020$46,000
-2.1%
10,696
-5.7%
0.01%0.0%
Q3 2020$47,000
-62.1%
11,347
-45.2%
0.01%
-88.4%
Q2 2020$124,00020,7070.07%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders